This genetic context may help provide insight into why your early response to semaglutide differs from othersand can support more informed dose-escalation conversations with your provider
It is critical that you join this lawsuit or work with our legal team to ensure your voice is heard
After the FDA approved Zepbound for moderate-to-severe OSA in December 2024, most UHC plans added an OSA coverage pathway
As a physical therapist and a certified lymphedema therapist (CLT-LANA), heres my take on what we know right now about GLP-1 for lymphedema patients
What Patients Should Expect: Continuity and Personalization Going Forward The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
However, Wegovy, which also uses semaglutide GLP-1 as an active ingredient, may be prescribed at a higher dosage than Ozempic